The FDA has approved St. Jude Medical Inc.'s multipoint pacing (MPP) technology for the company's Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D), the Quadra Allure MP CRT-pacemaker (CRT-P) and two new quadripolar Quartet LV leads.